By Colin Kellaher
SOPHiA GENETICS on Tuesday unveiled a pair of C-suite changes that include the hiring of a new chief financial officer.
SOPHiA said Ross Muken, who had been chief financial and operating officer of the Switzerland-based healthcare-technology company, is taking on the newly created role of president, overseeing its global business operations and working more closely on strategic planning with Chief Executive Jurgi Camblong.
SOPHiA said George Cardoza, most recently finance chief and head of service delivery at molecular-diagnostics company Biocartis, has joined the company as chief financial officer.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
November 05, 2024 07:25 ET (12:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.